No Data
No Data
Home Healthcare Inflation Is Stubbornly High -- WSJ
Express News | VolitionRx Announces Its First Commercial Sale Of Volition's High Throughput Synthetic Sepsis Method That Measures Neutrophil Extracellular Traps
Volition Signs First Commercial Project Utilizing Rapid High-Throughput Model in the Study of NETosis
Press Release: Volition to Host Virtual Investor Event on Nu.Q(R) NETs, "Casting a New Light on Sepsis Management", on February 14, 2025
Large Clinical Study Establishes Nu.Q NETs H3.1 as an Independent Predictor of 28-day Mortality in Sepsis
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN) and VolitionRX (VNRX)